PetMed Express, Inc. to Report Fourth Quarter and Fiscal Year 2026 Financial Results on Tuesday, June 2, 2026

DELRAY BEACH, Fla., May 29, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) today announced it will report financial results for the fourth quarter and fiscal year ended March 31, 2026, on Tuesday, June 2, 2026 after market close. The Company will host a conference call and webcast to discuss these results at 4:30pm Eastern Time on the same day.

Date: Tuesday, June 2, 2026
Time: 4:30pm Eastern Time (1:30pm Pacific Time)
U.S. dial-in number: 877-407-0789
International number: 201-689-8562
Webcast: 4Q Earnings Webcast

A telephonic replay of the conference call will also be available after 7:30 PM Eastern Time on the same day through June 16, 2026.

Toll-free replay number: 844-512-2921
International replay number: 412-317-6671
Replay passcode: 13760873

About PetMed Express, Inc.

Founded in 1996, PetMeds is a pioneer in the direct-to-consumer pet healthcare sector. As a trusted national online pharmacy, PetMeds is licensed across all 50 states and staffed with expert pharmacists dedicated to supporting pet wellness, pets and pet parents, and the veterinarians who serve them. Through its PETS family of brands and through its PetCareRx subsidiary, the Company offers a comprehensive range of pet health solutions - including top-brand and generic pharmaceuticals, compounded medications, and better-for-your-pet OTC supplements and nutrition. Focused on value, convenience, and care, PetMeds and PetCareRx empower pet parents to help their dogs, cats, and horses live longer, healthier lives. To learn more, visit www.PetMeds.com and www.PetCareRx.com.

Investor Contact:
ICR, LLC
Reed Anderson
(646) 277-1260
[email protected]

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Applied Biologics Announces Submission of Abstract of Single-Layer Amniotic Membrane Plus Standard of Care for Chronic Diabetic Foot Ulcers: An Updated Analysis of The Campx Trial to SAWC Fall 2026
• Skyline Exhibits Expands Amplify Modular Display System with New Structural Capabilities for Trade Show Exhibitors